HDFC Mutual FundHealthcareDirect plan, growth

HDFC Pharma and Healthcare Fund

Compare healthcare funds Compare with others

NAV: ₹21.95; —30 Oct 2026
AUM (₹ Cr): 3,128; Average, July - September 2026
Expense ratio: 1.05%; Regular 2.13%
Risk: Very High; SEBI riskometer

1Y return: 23.1%+12.3%; Benchmark 10.8%
3Y CAGR: 30.5%+7.8%; Benchmark 22.7%
5Y CAGR: —; Category 16.1%

Loading NAV history…

HDFC Pharma and Healthcare Fund

Rank in category

Too young for a combined rank, which needs five years. On its 1-year return it is #2 of 17.

Fund

SBI OpportunitiesSBI Healthcare Opportunities Fund#1#717.1%#224.6%#119.2%

Mirae AssetMirae Asset Healthcare Fund#2#518.5%#323.9%#316.6%

UTIUTI - Healthcare Fund#3#1113.5%#423.5%#416.2%

ICICI PrudentialICICI Prudential Healthcare Fund#4#165.1%#622.4%#216.7%

DSPDSP Healthcare Fund#5#915.0%#721.6%#516.2%

Aditya Birla Sun Life Pharma andAditya Birla Sun Life Pharma and Healthcare Fund#6#1014.2%#921.1%#714.8%

Tata India Pharma &Tata India Pharma & Healthcare Fund#7#174.3%#1119.3%#614.9%

Nippon India PharmaNippon India Pharma Fund#8#159.1%#1218.6%#814.2%

Bajaj FinservBajaj Finserv Healthcare Fund—#419.0%——

BandhanBandhan Healthcare Fund————

Baroda BNP Paribas Health and WellnessBaroda BNP Paribas Health and Wellness Fund—#1310.1%——

HDFC Pharma andHDFC Pharma and Healthcare Fund—#223.1%#130.5%—

Invesco India Pharma andInvesco India Pharma and Healthcare Fund————

ITI Pharma andITI Pharma and Healthcare Fund—#149.4%#1020.3%—

KotakKotak Healthcare Fund—#123.3%——

LIC MFLIC MF Healthcare Fund—#1211.0%#522.4%—

PGIM IndiaPGIM India Healthcare Fund—#618.1%——

quantquant Healthcare Fund—#815.3%#821.2%—

WhiteOak Capital Pharma andWhiteOak Capital Pharma and Healthcare Fund—#319.6%——

Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
Fund	0.0%	+0.7%	+16.7%	+24.0%	+23.1%	+30.5%	—	—	+29.3%
BSE Healthcare TRI	—	—	—	—	10.8%	22.7%	—	—	21.2%
Healthcare average	-0.3%	-0.9%	13.5%	16.7%	14.5%	22.4%	16.1%	14.7%	16.3%
Difference	—	—	—	—	+12.3%	+7.8%	—	—	+8.2%

Portfolio

Valuation

P/E: 48.5; Covers 96% of its shares
Category median: 48.4; 19 Healthcare funds
Benchmark P/E: 44.3; BSE Healthcare

P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 16 Oct 2026. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.

Fund details

Fund house: HDFC Mutual Fund
Category: Equity · Healthcare
SEBI classification: Equity / Sectoral / Thematic
Benchmark: BSE Healthcare TRI
Launch date: 4 Oct 2023 (3.1 years)
Structure: Open Ended
Plans and options: Direct Growth, Regular Growth
Fund manager: Nikhil Mathur
Minimum SIP: ₹100
Minimum lumpsum: ₹100 (then ₹100)
Exit load: 1.00%
Lock-in: None
Riskometer: Very High (benchmark Very High)
Expense ratio as of: 28 Oct 2026
AUM period: July - September 2026
ISIN, Direct Growth: INF179KC1HO1
ISIN, Regular Growth: INF179KC1HL7
Scheme code: 152082, 152084

NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other healthcare funds

Other funds in the Healthcare category.

Compare healthcare funds